PF04937319
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF04937319, covering 2017-01-31 to 2017-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes [Phase 2]